Javier B. Nieto-Rizo, Departamento de Neuroanestesiología, Instituto de Neurología y Neurocirugía Manuel Velasco Suárez, Ciudad de México, México
Sandra V. Cala-Rivas, Departamento de Anestesiología, Hospital General Dr. Manuel Gea González, Ciudad de México, México
Daniela Della-Valle, Departamento de Neuroanestesiología, Hospital Ángeles Centro Sur, Querétaro, Qro., México
Natanael Aranda-Guardia, Departamento de Neuroanestesiología, Hospital Ángeles Centro Sur, Querétaro, Qro., México
Eduardo A. Wilson-Manríquez, Departamento de Neuroanestesiología, Instituto de Neurología y Neurocirugía Manuel Velasco Suárez, Ciudad de México, México
Mariana G. Dámazo-del Río, Departamento de Neuroanestesiología, Instituto de Neurología y Neurocirugía Manuel Velasco Suárez, Ciudad de México, México
Samantha Bautista-Ordoñez, Departamento de Neuroanestesiología, Instituto de Neurología y Neurocirugía Manuel Velasco Suárez, Ciudad de México, México
Parkinson’s disease (PD) is a neurodegenerative disorder affecting more than 11 million people worldwide based on 2021 estimates, with a marked increase in global incidence and prevalence over recent decades. This upward trend has positioned PD as one of the fastest-growing neurological conditions, with profound implications for affected individuals and their primary caregivers. Beyond its direct clinical burden, PD imposes an escalating socioeconomic strain on healthcare systems and communities at large. As populations age, both the prevalence of PD and the frequency of comorbidity rise, leading to a growing number of surgical interventions in this population. Consequently, PD requires urgent attention and tailored strategies for perioperative care and long-term management. A scoping review was conducted with the aim of identifying and synthesizing the available evidence on the perioperative management of patients with Parkinson’s disease. The review follows the methodological recommendations described in the PRISMA-ScR extension for scoping reviews. Special emphasis is placed on perioperative risk stratification and the continuity of dopaminergic therapy, both of which are critical to prevent neurological deterioration and perioperative complications.
Keywords: Parkinson's disease. Perioperative management. Anesthesiology.